SP
AUTL

SIH Partners’s Autolus Therapeutics AUTL Stock Holding History

SIH Partners’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Hold
14,887
– – ﹤0.01% 318
2026
Q1 		$20.5K Hold
14,887
– – ﹤0.01% 289
2025
Q4 		$29.6K Buy
14,887
+4,027
+37% +$6.19K ﹤0.01% 205
2025
Q3 		$17.7K Buy
+10,860
New +$21.2K ﹤0.01% 226

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SIH Partners's AUTL Position: Q2 2026 in Review

SIH Partners held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 14,887 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

SIH Partners first reported a position in AUTL in Q3 2025 and has held it in 4 quarters since. The position peaked at $29.6K in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • SIH Partners held 14,887 shares of Autolus Therapeutics worth $23.8K as of Q2 2026.
  • SIH Partners left its Autolus Therapeutics share count unchanged in Q2 2026.
  • Autolus Therapeutics made up ﹤0.01% of SIH Partners's portfolio in Q2 2026, its #318 holding.
  • SIH Partners first reported a position in Autolus Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • SIH Partners's Autolus Therapeutics position peaked at $29.6K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.